Robert W. Postma - 24 Jun 2025 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Jun 2025, 21:19:44 UTC
Prior SEC filing
15 Apr 2025
Next SEC filing
07 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Melinda Lackey, Attorney-in-Fact

Key filing fact

Robert W. Postma filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 26 Jun 2025.

Key facts

  • This page summarizes Robert W. Postma's Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 26 Jun 2025, 21:19.

Change

  • Previous filing in this sequence was filed on 15 Apr 2025.
  • Current net transaction value: +$64,822.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001827847 Primary reporting owner

Postma Robert W

Relationship
Director
Address
C/O ALAUNOS THERAPEUTICS, INC., 2617 BISSONNET ST, SUITE 233, HOUSTON
Signature
/s/ Melinda Lackey, Attorney-in-Fact
Signature date
26 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TCRT transaction

Common Stock

Award

Transaction value
$60,748
Shares
+20,804
Change %
+251%
Price
$2.92
Shares after
29,083
Date
13 Apr 2025
Ownership
Direct
TCRT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
24
Date
24 Jun 2025
Ownership
By spouse's IRA
TCRT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
33,333
Date
24 Jun 2025
Ownership
By WaterMill Asset Management Corp.
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TCRT transaction Derivative

Series A-1 Convertible Preferred Stock

Purchase

Transaction value
$1,380
Shares
+500
Change %
Price
$2.76
Shares after
500
Date
11 Apr 2025
Ownership
By WaterMill Asset Management Corp.
Underlying class
Common Stock
Underlying amount
181,159
Exercise price
$2.76
Footnotes
F1, F2, F3
TCRT transaction Derivative

Series A-2 Convertible Preferred Stock

Purchase

Transaction value
$2,694
Shares
+600
Change %
Price
$4.49
Shares after
600
Date
24 Jun 2025
Ownership
By Watermill Asset Management Corp
Underlying class
Common Stock
Underlying amount
133,630
Exercise price
$4.49
Footnotes
F1, F2
TCRT holding Derivative

Employee Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,737
Date
24 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,737
Exercise price
$10.30
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.

Footnote F2

The preferred stock is perpetual and therefore has no expiration date.

Footnote F3

The reporting person disclaims beneficial ownership of these equity securities to the extent that after giving effect of the conversion of the preferred stock and the underlying common stock issuance, the reporting person would beneficially own in the aggregate in excess of 4.99% of the outstanding shares immediately after giving effect to such conversion or issuance.

Footnote F4

One-twelfth of the Option vests each month on the monthly anniversary of June 6, 2024, with any amount that remains unvested on the date immediately preceding the Company's 2025 annual general meeting of stockholders vesting thereon.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .